Inhaled Glucocorticoids in Rhinosinusitis: A Few Pharmacological Aspects, We Must Know

JOURNAL TITLE: Clinical Rhinology

Author
1. JS Thakur
2. NK Mohindroo
3. DR Sharma
4. Anamika Thakur
ISSN
0974-4630
DOI
10.5005/jp-journals-10013-1046
Volume
3
Issue
3
Publishing Year
2010
Pages
2
Author Affiliations
    1. Department of ENT and Head and Neck Surgery, IG Medical College, Shimla, Himachal Pradesh, India
    1. Department of ENT and Head and Neck Surgery, IG Medical College, Shimla, Himachal Pradesh, India
    1. Department of ENT and Head and Neck Surgery, IG Medical College, Shimla, Himachal Pradesh, India
    1. Department of Pharmacology, Indira Gandhi Medical College, Shimla, Himachal Pradesh, India
  • Article keywords
    Atopy, Inflammation, Fluticasone, Beclomethasone, Ciclesonide, Flunisolide, Budesonide

    Abstract

    Inhaled glucocorticoids are very effective for the management of seasonal and perennial allergic rhinitis. Various glucocorticoids are available for inhalation therapy with varying affinity for the receptors. Inhaled glucocorticoids have very low incidence of systemic side effects at the usual therapeutic doses. In this review we have discussed the pharmacokinetics, pharmacodynamics and adverse effects profile of the commonly available inhaled glucocorticoids.

    © 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved